Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication

Published:2022-01 Issue:1 Volume:86 Page:42-43
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Murphrey Morgan,Waldman Reid Alexander,Durso Timothy,Grant-Kels Jane M.

Funder

Eli Lilly and Company

AbbVie

Publisher

Elsevier BV

Subject

Dermatology

Reference1 articles.

1. Janus kinase inhibitors in dermatology: part I. A comprehensive review;Chapman;J Am Acad Dermatol,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitors for the treatment of vitiligo;Journal of Dermatological Science;2024-03

2. Cutaneous T-cell lymphoma in a JAK inhibitor patient: A case report;SAGE Open Medical Case Reports;2024-01

3. Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?;The Journal of Dermatology;2023-12-12

4. JAK inhibitors and black box warnings: what is the future for JAK inhibitors?;Expert Review of Clinical Immunology;2023-09-04

5. The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials;Journal of Cosmetic Dermatology;2023-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP